Ormeloxifene induces mitochondrial fission-mediated pro-death autophagy in colon cancer cells
Rakesh Kumar Sharma1, Rohit Sahai2, Nishakumari Chentunarayan Singh2
1Electron Microscopy Unit, Sophisticated Analytical Instrument Facility and Research, CSIR - Central Drug Research Institute, Sector-10, Jankipuram Extension, Lucknow, Uttar Pradesh, 226 031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
Abstract:
Ormeloxifene (ORM) is a nonsteroidal selective estrogen receptor modulator (SERM), developed by the CSIR-Central Drug Research Institute that is approved as an oral contraceptive. However, it has also shown promising anti-cancer activity, especially in breast cancer. Here, we have investigated the anti-cancer effect of ORM on colon cancer cells and show that its antiproliferative activity is mediated through mitochondrial fission and autophagy-associated cell death. We observed that ORM treatment led to an elevation in autophagy markers like LC3II, Beclin1, and Atg7. Autophagy induction and LC3II turnover were monitored by immunofluorescence staining and confocal microscopy. Transmission electron microscopy results confirmed the formation of autophagosomes and autophagolysosomes. Autophagic flux was confirmed by the increased expression of LC3II in cells co-treated with BafilomycinA1(autophagy inhibitor) and ORM. This was further corroborated using tandem mRFP-GFP-LC3 (tfLC3) transfection in DLD-1 cells. Interestingly, we observed that inhibition of autophagy reduced the apoptotic cell population, suggesting pro-death autophagy. ORM treatment caused notable ultrastructural alterations indicative of cellular stress. Notably, ORM triggered the generation of mitochondrial ROS, associated with increased levels of mitochondrial fission and a decrease in mitochondrial fusion proteins. Changes in mitochondrial dynamics were observed under the TEM, which included reduced mitochondrial size and increased mitochondrial number. Inhibition of mitochondrial fission resulted in enhanced cell survival and a concomitant decrease in the autophagic markers, implying that ORM-induced autophagy depends on mitochondrial fission. Taken together, our findings bring to light a novel mechanism where Ormeloxifene targets mitochondrial dynamics to promote autophagy-associated cell death in colon cancer cells.
Insights
Ormeloxifene (ORM) induces colon cancer cell death by promoting mitochondrial fission and autophagy. Inhibiting autophagy or mitochondrial fission reduces ORM
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Ormeloxifene (ORM), a selective estrogen receptor modulator (SERM), is an oral contraceptive with demonstrated anti-cancer properties, particularly in breast cancer.
- Its potential anti-cancer effects in colon cancer warrant further investigation.
Purpose of the Study:
- To investigate the anti-cancer effects of Ormeloxifene (ORM) on colon cancer cells.
- To elucidate the underlying mechanisms, focusing on mitochondrial dynamics and autophagy-associated cell death.
Main Methods:
- Utilized immunofluorescence staining, confocal microscopy, and transmission electron microscopy (TEM) to assess autophagy markers (LC3II, Beclin1, Atg7) and autophagosome formation.
- Confirmed autophagic flux using Bafilomycin A1 co-treatment and tandem mRFP-GFP-LC3 (tfLC3) transfection.
- Analyzed mitochondrial dynamics, including reactive oxygen species (ROS) generation, mitochondrial fission/fusion protein levels, and ultrastructural changes via TEM.
- Investigated the role of mitochondrial fission by inhibiting it and observing effects on cell survival and autophagy.
Main Results:
- ORM treatment significantly elevated autophagy markers and induced autophagosome/autophagolysosome formation in colon cancer cells.
- ORM triggered mitochondrial reactive oxygen species (ROS) generation, increased mitochondrial fission, and decreased mitochondrial fusion.
- Inhibition of autophagy reduced ORM-induced apoptosis, indicating pro-death autophagy.
- Blocking mitochondrial fission enhanced cell survival and decreased autophagic markers, suggesting ORM-induced autophagy is dependent on mitochondrial fission.
Conclusions:
- Ormeloxifene (ORM) exhibits anti-cancer activity in colon cancer cells through a novel mechanism involving mitochondrial dynamics.
- ORM promotes autophagy-associated cell death, which is critically dependent on mitochondrial fission.
- Targeting mitochondrial dynamics represents a potential therapeutic strategy for colon cancer using ORM.
More Related Videos
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
04:20Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy
